Bigfoot Biomedical Company
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
Technology:
P4 Medicine
Industry:
AI, United States, mHealth
Headquarters:
Milpitas, California, United States
Zip:
101-250
Founded Date:
2014-11-18
Employees Number:
101-250
Funding Status:
Late Stage Venture
Acquisitions Number:
15
Investors Number:
204628488
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Convertible Note
Last Funding Type:
info@bigfootbiomedical.com
Register and Claim Ownership